Remove 2040 Remove Chronic Pain Remove Data Remove Therapy
article thumbnail

MyMD Pharmaceuticals President Chris Chapman, M.D. Named Medical Honoree of the Year by the Arthritis Foundation

Cannabis Law Report

Studies estimate that the number of people suffering from rheumatoid arthritis may rise to over 78 million by 2040. a driver of chronic inflammation. Unlike other therapies, MYMD-1 has been shown to selectively block TNF-? 1 Data published by Research and Markets, March 2018. MyMD: Robert Schatz. 646) 421-9523.